Heba H. Mostafa

5.3k total citations
106 papers, 2.0k citations indexed

About

Heba H. Mostafa is a scholar working on Infectious Diseases, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Heba H. Mostafa has authored 106 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 48 papers in Epidemiology and 15 papers in Biomedical Engineering. Recurrent topics in Heba H. Mostafa's work include SARS-CoV-2 and COVID-19 Research (30 papers), SARS-CoV-2 detection and testing (29 papers) and Respiratory viral infections research (24 papers). Heba H. Mostafa is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (30 papers), SARS-CoV-2 detection and testing (29 papers) and Respiratory viral infections research (24 papers). Heba H. Mostafa collaborates with scholars based in United States, Egypt and Germany. Heba H. Mostafa's co-authors include David J. Davido, Karen C. Carroll, C. Paul Morris, Andrew Pekosz, Eili Klein, Mirna Perusina Lanfranca, Patricia J. Simner, Lynda A. Morrison, Stuart J. Macdonald and Michael Forman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and Clinical Infectious Diseases.

In The Last Decade

Heba H. Mostafa

99 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba H. Mostafa United States 23 1.0k 761 433 254 194 106 2.0k
Jingwen Ai China 26 1.1k 1.1× 916 1.2× 537 1.2× 205 0.8× 117 0.6× 86 2.3k
Vincent Enouf France 27 1.3k 1.3× 1.1k 1.4× 375 0.9× 107 0.4× 170 0.9× 79 2.6k
John A. Branda United States 25 1.8k 1.7× 389 0.5× 484 1.1× 123 0.5× 148 0.8× 112 2.8k
Yiyue Ge China 23 859 0.8× 501 0.7× 586 1.4× 216 0.9× 230 1.2× 49 1.9k
Daniel S. Chertow United States 20 955 0.9× 719 0.9× 337 0.8× 95 0.4× 246 1.3× 58 1.9k
David R. Martinez United States 20 1.1k 1.0× 348 0.5× 282 0.7× 43 0.2× 320 1.6× 62 1.8k
Ran Nir‐Paz Israel 27 449 0.4× 869 1.1× 382 0.9× 80 0.3× 217 1.1× 98 2.2k
Jason J. LeBlanc Canada 20 616 0.6× 437 0.6× 324 0.7× 233 0.9× 88 0.5× 72 1.3k
Christoph Steininger Austria 24 565 0.6× 937 1.2× 223 0.5× 75 0.3× 182 0.9× 69 1.8k
Olivier Épaulard France 22 614 0.6× 518 0.7× 201 0.5× 36 0.1× 143 0.7× 101 1.5k

Countries citing papers authored by Heba H. Mostafa

Since Specialization
Citations

This map shows the geographic impact of Heba H. Mostafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba H. Mostafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba H. Mostafa more than expected).

Fields of papers citing papers by Heba H. Mostafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba H. Mostafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba H. Mostafa. The network helps show where Heba H. Mostafa may publish in the future.

Co-authorship network of co-authors of Heba H. Mostafa

This figure shows the co-authorship network connecting the top 25 collaborators of Heba H. Mostafa. A scholar is included among the top collaborators of Heba H. Mostafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba H. Mostafa. Heba H. Mostafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fall, Amary, et al.. (2024). Mpox Recurrence and Tecovirimat Resistance in a Patient With Advanced Human Immunodeficiency Virus Disease. Open Forum Infectious Diseases. 11(10). ofae549–ofae549. 4 indexed citations
2.
3.
Fogel, Jessica M., Vanessa Cummings, Heba H. Mostafa, et al.. (2024). Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiology Spectrum. 12(8). e0030724–e0030724. 3 indexed citations
4.
Bersoff‐Matcha, Susan, Andrew Pekosz, Heba H. Mostafa, et al.. (2024). A scoping review of global COVID-19 vaccine hesitancy among pregnant persons. npj Vaccines. 9(1). 131–131. 12 indexed citations
5.
Manabe, Yukari C., et al.. (2024). Retrospective Monkeypox Virus Surveillance Among Male Users of I Want the Kit in Maryland, United States. Clinical Infectious Diseases. 79(1). 138–140.
6.
Rothman, Richard E., Yu‐Hsiang Hsieh, Susan H. Eshleman, et al.. (2023). Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trial. BMC Infectious Diseases. 23(1). 570–570. 1 indexed citations
7.
Jones, Joyce, Heba H. Mostafa, Seth D. Judson, et al.. (2023). Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox. Open Forum Infectious Diseases. 10(12). ofad533–ofad533. 8 indexed citations
8.
Robinson, Matthew L., C. Paul Morris, Joshua Betz, et al.. (2022). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome. Clinical Infectious Diseases. 76(9). 1539–1549. 17 indexed citations
9.
Morris, C. Paul, Raghda E. Eldesouki, Jaiprasath Sachithanandham, et al.. (2022). Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization. Clinical Infectious Diseases. 76(7). 1276–1284. 9 indexed citations
10.
Zhang, Sean X., et al.. (2022). Characterizing the microbiota of instrumentation in ophthalmology clinics during and beyond the COVID-19 pandemic. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(8). 2585–2590. 1 indexed citations
11.
Woldemeskel, Bezawit A., Caroline C. Garliss, Evan J. Beck, et al.. (2022). SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge. JCI Insight. 7(10). 12 indexed citations
12.
Dioverti, M. Veronica, David C. Gaston, C. Paul Morris, et al.. (2022). Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients. Open Forum Infectious Diseases. 9(6). ofac064–ofac064. 18 indexed citations
13.
14.
Feder, Kenneth A., Ami B. Patel, Venkata R. Vepachedu, et al.. (2021). Association of E484K Spike Protein Mutation With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Persons: Maryland, January–May 2021. Clinical Infectious Diseases. 74(11). 2053–2056. 8 indexed citations
15.
Credle, Joel J., Matthew L. Robinson, Jonathan Gunn, et al.. (2021). Highly multiplexed oligonucleotide probe-ligation testing enables efficient extraction-free SARS-CoV-2 detection and viral genotyping. Modern Pathology. 34(6). 1093–1103. 11 indexed citations
16.
Gniazdowski, Victoria, C. Paul Morris, Shirlee Wohl, et al.. (2020). Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds. Clinical Infectious Diseases. 73(4). e860–e869. 100 indexed citations
17.
Mostafa, Heba H., Daryl M. Lamson, Jessica N. Brazelton, et al.. (2020). Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test. Journal of Clinical Virology. 130. 104583–104583. 19 indexed citations
18.
Mostafa, Heba H., John A. Fissel, Brian Fanelli, et al.. (2020). Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients. mBio. 11(6). 116 indexed citations
19.
Mostafa, Heba H., Karen C. Carroll, Gregory J. Berry, et al.. (2020). Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test. Journal of Clinical Microbiology. 59(3). 61 indexed citations
20.
Malek, Adel, Samantha Taffner, Lynn Fine, et al.. (2019). Next-Generation-Sequencing-Based Hospital Outbreak Investigation Yields Insight into Klebsiella aerogenes Population Structure and Determinants of Carbapenem Resistance and Pathogenicity. Antimicrobial Agents and Chemotherapy. 63(6). 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingwen Ai Breakdown of academic impact, for papers by Vincent Enouf Breakdown of academic impact, for papers by John A. Branda Breakdown of academic impact, for papers by Yiyue Ge Breakdown of academic impact, for papers by Daniel S. Chertow Breakdown of academic impact, for papers by David R. Martinez Breakdown of academic impact, for papers by Ran Nir‐Paz Breakdown of academic impact, for papers by Jason J. LeBlanc Breakdown of academic impact, for papers by Christoph Steininger Breakdown of academic impact, for papers by Olivier Épaulard
Rankless by CCL
2026